Hainan Huluwa Pharmaceutical Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 913.98 million compared to CNY 733.46 million a year ago. Revenue was CNY 913.98 million compared to CNY 733.46 million a year ago.

Net income was CNY 61.36 million compared to CNY 57.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.15 compared to CNY 0.14 a year ago.